SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-080831
Filing Date
2013-11-05
Accepted
2013-11-05 08:01:10
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19642_110q.htm 10-Q 957864
2 EX-31.1 a13-19642_1ex31d1.htm EX-31.1 13442
3 EX-31.2 a13-19642_1ex31d2.htm EX-31.2 12716
4 EX-32.1 a13-19642_1ex32d1.htm EX-32.1 6707
  Complete submission text file 0001104659-13-080831.txt   5761429

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rigl-20130930.xml EX-101.INS 665461
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rigl-20130930.xsd EX-101.SCH 62649
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rigl-20130930_cal.xml EX-101.CAL 36309
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rigl-20130930_lab.xml EX-101.LAB 938681
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rigl-20130930_pre.xml EX-101.PRE 454579
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rigl-20130930_def.xml EX-101.DEF 283250
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 131190886
SIC: 2834 Pharmaceutical Preparations